InvestorsHub Logo
Followers 36
Posts 2689
Boards Moderated 0
Alias Born 06/09/2011

Re: None

Thursday, 01/06/2022 4:56:03 AM

Thursday, January 06, 2022 4:56:03 AM

Post# of 688729
Found this interesting regarding Charles River Labs website feature on January 3, 2022 my highlights in BOLD: IMHO they are Manufacturing Ready for DCVax!

The promise offered by cell and gene therapies is currently tempered by the many challenges associated with developing them. Identifying a partner that can help guide, innovate, and navigate around them is a critical success factor for any program. Committed to this form of collaboration and support for our cell and gene therapy clients, we are pleased to announce the full integration of Cognate BioServices, Cobra Biologics, Vigene Biosciences, Hemacare, Cellero, Distributed Bio, Retrogenix into Charles River.

Today’s announcement marks another key milestone in our mission to invest in the tools, talent, and capacity to further the new frontier of regenerative medicine. With the benefit of a shared quality system, faster internal technical transfer, and process crossover between teams helping to reduce program bottlenecks and providing a seamless experience, we are now uniquely positioned to help our clients accelerate and achieve critical development goals from discovery to commercialization.

We have supported the development of 10 FDA-approved cell and gene therapies and have conducted more than 900 studies in this field over the past year. A key aim of this integration is to enhance client access to this wealth of scientific and regulatory experience as well as harnesses the power of our multidisciplinary bench of experts to problem solve in a collaborative manner every step of the way.

https://www.criver.com/insights/charles-river-integrates-cell-and-gene-therapy-acquisitions-enhance-end-end-offering-developers
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News